The purpose of immunotherapy in tongue cancer is to remove the cancer cells or control the growth of the cancer cells by restoring the natural function of the immune cells, T cells are stimulated and strengthened in vitro, so that after being introduced back to patient’s body, they will be able to identify the tongue cancer cells and destroy them.
Proteins such as CK19, SPANX, CEA and a few others are presented on the surface of the tongue cancer cells, they are recognized by the immune system as ‘foreign’ to the human body, and are supposed to be destroyed by the T cells in the immune system. However, immune system’s failure in identifying these proteins, causing uncontrolled growth of the tongue cancer cells.
Tongue cancer is a type of oral cancer that forms in the front two-thirds of the tongue. Cancer that forms in the back one third of the tongue is considered a type of head and neck cancer.
Tongue cancer usually develops in the squamous cells, the thin, flat cells that cover the surface of the tongue.
Symptoms of tongue cancer are very similar to symptoms of other types of oral cancer. It can often be mistaken for a cold that won’t go away, or a persistent sore in the mouth. Other tongue cancer symptoms and signs may include:
NOTE: These symptoms may be attributed to a number of conditions other than cancer. It is important to consult with a medical professional for an accurate diagnosis.
Common tongue cancer treatments include:
Surgery: Tumor resection involves an operation to remove the entire tumor from the tongue. Minimally invasive surgical techniques are used whenever possible to treat tongue cancer.
Radiation therapy: Your radiation oncologist will administer radiation therapy to cancerous tissues of the tongue, using a high dose with pinpoint accuracy, sparing healthy tissue and shortening procedure times.
Chemotherapy: Often combined with radiation therapy, chemotherapy uses anticancer drugs to destroy cancer cells throughout the body. It may be an option if the cancer has spread to nearby lymph nodes. Different chemotherapy drugs can be combined to attack cancer cells at varying stages of their growth cycles and decrease the chance of drug resistance.
Targeted drug therapy: Targeted drug therapy targets cancerous cells to interfere with cell growth on a molecular level. It is often combined with chemotherapy and/or radiation therapy as part of a tongue cancer treatment plan.
China has seen rapid growth in its biotech industry, particularly in the area of CAR T-cell therapy. Many Chinese biotech firms have developed their own CAR T-cell therapies and are actively seeking partnerships with international pharmaceutical companies. As the second-largest country in terms of the number of CAR T-cell therapy clinical trials, China’s research efforts reflect its commitment to advancing this innovative treatment approach.
Moreover, China has implemented various measures to make CAR T-cell therapy more accessible and affordable for patients. These patient-friendly pricing strategies have indeed contributed to making China an attractive destination for international patients for innovative therapies like CAR T-cell therapy. Comparatively, the cost of CAR T-cell therapy in China may be relatively more affordable than in other countries.
Contact us and get detailed information about getting advanced immunotherapy and CAR T-cell therapy for the treatment of solid tumors, blood cancers and HPV infection.